WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Douglas Katsev, MD, and Julia Katsev Larson, OD, discuss the use of Miebo for dry eye disease.“Miebo (perfluorohexyloctane ophthalmic solution, Bausch + Lomb) is a great addition…
Global Sports Optics Analysis 2023: A $2.73 Billion Market by 2029 Featuring Key vendors – Nikon, Swarovski, Beretta, Vortex, Leica Camera, Carlyle group, ATN, and Trijicon Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Sports Optics Market: Analysis By Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029” report has been added to ResearchAndMarkets.com’s offering. The global sports optics market value st…
Geographic atrophy treatment Izervay receives permanent J-code
CMS has assigned a permanent J-code for Izervay for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Iveric Bio.The new code for Izervay (avacincaptad pegol intravitreal solution) for …
Opus Genetics completes dosing in first cohort of Leber congenital amaurosis trial
Dosing is complete in the first cohort of the phase 1/2 clinical trial of OPGx-LCA5 for the treatment of Leber congenital amaurosis, according to a press release from Opus Genetics.An adeno-associated virus 8 vector is used to deliver a functional LCA5…
Empowering the Future of Optometry: Axcel Learning Partners with KMK Optometry to Redefine Board Exam Preparation
SAN FRANCISCO & OMAHA, Neb.–(BUSINESS WIRE)–Axcel Learning (Axcel), a professional education business backed by Alpine Investors (Alpine), today announced a new partnership with KMK Optometry (KMK), the premier provider of comprehensive optometry boa…
Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has dosed the first Canadian subject in its Phase 1 / 2 c…